United States Food and Drug Administration (USFDA) has completed inspection at FDC’s manufacturing plant located at B-8, MIDC Industrial Area, Waluj, Aurangabad, Maharashtra, which manufactures sterile ophthalmic products from February 6, 2023 to February 12, 2023.The said audit has been successfully completed by the USFDA with No observations (Zero 483’s). The audit was carried out for the sterile ophthalmic products being marketed in the US.
FDC made a modest beginning with marketing of vitamins and a range of prescription formulations. The company subsequently set up their formulations manufacturing facility and also pioneered the manufacture of specialized ophthalmic formulations in India.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: